Indeed, this mouse model is suitable for the in vivo study of the MGO-dependent effects, as its characteristic feature is represented by reduced levels of Glo1 that are responsible for the accumulation of MGO-modified proteins and the development of diabetic complications in the absence of hyperglycemia [22,23]. The gene discussed is GLO1; the disease is Hyperglycemia.